Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Harvard Bioscience stock
Learn how to easily invest in Harvard Bioscience stock.
Harvard Bioscience Inc is a medical instruments & supplies business based in the US. Harvard Bioscience shares (HBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Harvard Bioscience employs 475 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Harvard Bioscience
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HBIO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Harvard Bioscience stock price (NASDAQ: HBIO)Use our graph to track the performance of HBIO stocks over time.
Harvard Bioscience shares at a glance
|Latest market close||$3.70|
|52-week range||$3.25 - $8.75|
|50-day moving average||$4.13|
|200-day moving average||$5.96|
|Wall St. target price||$10.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.16|
Buy Harvard Bioscience shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Harvard Bioscience stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Harvard Bioscience price performance over time
|1 week (2022-06-28)||1.09%|
|1 month (2022-06-01)||3.93%|
|3 months (2022-04-05)||-40.32%|
|6 months (2022-01-05)||-44.36%|
|1 year (2021-07-02)||-55.04%|
|2 years (2020-07-02)||1.93%|
|3 years (2019-07-05)||94.74%|
|5 years (2017-07-03)||42.31%|
Is Harvard Bioscience stock undervalued or overvalued?
Valuing Harvard Bioscience stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Harvard Bioscience's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Harvard Bioscience's PEG ratio
Harvard Bioscience's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.89. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Harvard Bioscience's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Harvard Bioscience's EBITDA
Harvard Bioscience's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.7 million.
The EBITDA is a measure of a Harvard Bioscience's overall financial performance and is widely used to measure a its profitability.
Harvard Bioscience financials
|Revenue TTM||$120.7 million|
|Operating margin TTM||0.15%|
|Gross profit TTM||$67.7 million|
|Return on assets TTM||0.07%|
|Return on equity TTM||-8.47%|
|Market capitalisation||$152.6 million|
TTM: trailing 12 months
Harvard Bioscience share dividends
We're not expecting Harvard Bioscience to pay a dividend over the next 12 months.
Have Harvard Bioscience's shares ever split?
Harvard Bioscience's shares were split on a 1319:1000 basis on 3 November 2013. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1319 shares. This wouldn't directly have changed the overall worth of your Harvard Bioscience shares – just the quantity. However, indirectly, the new 24.2% lower share price could have impacted the market appetite for Harvard Bioscience shares which in turn could have impacted Harvard Bioscience's share price.
Harvard Bioscience share price volatility
Over the last 12 months, Harvard Bioscience's shares have ranged in value from as little as $3.25 up to $8.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harvard Bioscience's is 1.8761. This would suggest that Harvard Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Harvard Bioscience overview
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Harvard Bioscience in the news
Are Options Traders Betting on a Big Move in Harvard Bioscience (HBIO) Stock?
Frequently asked questionsWhat percentage of Harvard Bioscience is owned by insiders or institutions?
Currently 11.519% of Harvard Bioscience shares are held by insiders and 77.659% by institutions. How many people work for Harvard Bioscience?
Latest data suggests 475 work at Harvard Bioscience. When does the fiscal year end for Harvard Bioscience?
Harvard Bioscience's fiscal year ends in December. Where is Harvard Bioscience based?
Harvard Bioscience's address is: 84 October Hill Road, Holliston, MA, United States, 01746 What is Harvard Bioscience's ISIN number?
Harvard Bioscience's international securities identification number is: US4169061052 What is Harvard Bioscience's CUSIP number?
Harvard Bioscience's Committee on Uniform Securities Identification Procedures number is: 416906105
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert